{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:34:01Z","timestamp":1789540441588,"version":"build-2803163510"},"reference-count":19,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Somatic mutations of the spliceosomal machinery occur frequently in adult patients with myelodysplastic syndrome (MDS). We resequenced SF3B1, U2AF35, and SRSF2 in 371 children with MDS or juvenile myelomonocytic leukemia. We found missense mutations in 2 juvenile myelomonocytic leukemia cases and in 1 child with systemic mastocytosis with MDS. In 1 juvenile myelomonocytic leukemia patient, the SRSF2 mutation that initially coexisted with an oncogenic NRAS mutation was absent at relapse, whereas the NRAS mutation persisted and a second, concomitant NRAS mutation later emerged. The patient with systemic mastocytosis and MDS carried both mutated U2AF35 and KIT in a single clone as confirmed by clonal sequencing. In the adult MDS patients sequenced for control purposes, we detected previously reported mutations in 7\/30 and a novel SRSF2 deletion (c.284_307del) in 3 of 30 patients. These findings implicate that spliceosome mutations are rare in pediatric MDS and juvenile myelomonocytic leukemia and are unlikely to operate as driver mutations.<\/jats:p>","DOI":"10.1182\/blood-2011-12-395087","type":"journal-article","created":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T05:58:13Z","timestamp":1326347893000},"page":"e96-e99","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":59,"title":["Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML"],"prefix":"10.1182","volume":"119","author":[{"given":"Shinsuke","family":"Hirabayashi","sequence":"first","affiliation":[{"name":"Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Flotho","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Moetter","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heuser","sequence":"additional","affiliation":[{"name":"Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Hasle","sequence":"additional","affiliation":[{"name":"Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Gruhn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital Jena, Jena, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klingebiel","sequence":"additional","affiliation":[{"name":"Pediatric Hematology, Oncology and Hemostaseology, University of Frankfurt, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Thol","sequence":"additional","affiliation":[{"name":"Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Schlegelberger","sequence":"additional","affiliation":[{"name":"Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irith","family":"Baumann","sequence":"additional","affiliation":[{"name":"Department of Pathology, Clinical Centre South West, B\u00f6blingen Clinics, B\u00f6blingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Strahm","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Stary","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Bambino Ges\u00f9, Rome, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zecca","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Bergstraesser","sequence":"additional","affiliation":[{"name":"Hematology and Oncology, University Children's Hospital, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dworzak","sequence":"additional","affiliation":[{"name":"St Anna Children's Hospital, Department of Pediatrics, Medical University Vienna, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marry M.","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Erasmus MC, Rotterdam, The Netherlands;"},{"name":"Dutch Childhood Oncology Group, The Hague, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"De Moerloose","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Cancer Genomics Project, Graduate School of Medicine, University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"Niemeyer","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin W.","family":"Wlodarski","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the European Working Group of MDS in Childhood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7367","key":"2019111807200663800_B1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia.","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"issue":"15","key":"2019111807200663800_B2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N Engl J Med"},{"key":"2019111807200663800_B3","article-title":"SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts [published online ahead of print September 2, 2011].","author":"Visconte","journal-title":"Leukemia"},{"issue":"4","key":"2019111807200663800_B4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ccr.2011.10.004","article-title":"The spliceosome as an indicted conspirator in myeloid malignancies.","volume":"20","author":"Abdel-Wahab","year":"2011","journal-title":"Cancer Cell"},{"issue":"3","key":"2019111807200663800_B5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s002770050488","article-title":"Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor.","volume":"78","author":"Hofmann","year":"1999","journal-title":"Ann Hematol"},{"issue":"3","key":"2019111807200663800_B6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.leu.2403239","article-title":"A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes.","volume":"18","author":"Stadler","year":"2004","journal-title":"Leukemia"},{"issue":"3","key":"2019111807200663800_B7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1200\/JCO.2010.31.2686","article-title":"Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care-SAKK 33\/99.","volume":"29","author":"Passweg","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111807200663800_B8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0609.1989.tb00300.x","article-title":"Oral iron chelators: prospects for future development.","volume":"43","author":"Porter","year":"1989","journal-title":"Eur J Haematol"},{"issue":"8","key":"2019111807200663800_B9","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood-2004-10-4045","article-title":"Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia.","volume":"106","author":"Wlodarski","year":"2005","journal-title":"Blood"},{"key":"2019111807200663800_B10","first-page":"104","article-title":"Childhood myelodysplastic syndrome.","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Baumann","year":"2008"},{"issue":"2","key":"2019111807200663800_B11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.leu.2402765","article-title":"A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.","volume":"17","author":"Hasle","year":"2003","journal-title":"Leukemia"},{"issue":"2","key":"2019111807200663800_B12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.2011.08724.x","article-title":"Advances in the prognostication and management of advanced MDS in children.","volume":"154","author":"Hasle","year":"2011","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111807200663800_B13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2019111807200663800_B14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/jcp.2009.067876","article-title":"KIT(D816V+) systemic mastocytosis associated with KIT(D816V+) acute erythroid leukaemia: first case report with molecular evidence for same progenitor cell derivation.","volume":"62","author":"McClintock-Treep","year":"2009","journal-title":"J Clin Pathol"},{"issue":"5","key":"2019111807200663800_B15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.leukres.2008.09.027","article-title":"Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.","volume":"33","author":"Ustun","year":"2009","journal-title":"Leuk Res"},{"issue":"16","key":"2019111807200663800_B16","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1182\/blood-2011-07-370684","article-title":"Abnormal promoter DNA methylation in juvenile myelomonocytic leukemia is not caused by mutation in DNMT3A.","volume":"118","author":"Wlodarski","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2019111807200663800_B17","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood-2009-06-226340","article-title":"Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia.","volume":"115","author":"Muramatsu","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111807200663800_B18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2141.2010.08196.x","article-title":"Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations.","volume":"150","author":"Sugimoto","year":"2010","journal-title":"Br J Haematol"},{"issue":"11","key":"2019111807200663800_B19","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/leu.2011.142","article-title":"Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groups.","volume":"25","author":"Damm","year":"2011","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/11\/e96\/1351636\/zh801112000e96.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/11\/e96\/1351636\/zh801112000e96.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T16:17:51Z","timestamp":1713370671000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/11\/e96\/29668\/Spliceosomal-gene-aberrations-are-rare-coexist"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,15]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,3,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-12-395087","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,15]]}}}